Abuse of the mushroom Panaeolus foenisecii.
BMJ – February 16, 1980
Source: OpenAlex
Summary
The *Panaeolus foenesecii* mushroom presents a fascinating complexity for Plant-based Medicinal Research: psilocybin and psilocin, compounds with potential for Medicine and even Cancer Treatment, are inconsistently present. While approximately 60% of analyzed specimens contain these substances, others do not, leading to its classification as a "latent psilocybin" mushroom. This variability complicates precise pharmacological understanding and raises concerns about Mushroom poisoning. Leveraging Data science and Computer science to analyze chemical profiles, perhaps by collating global reports from the World Wide Web, is crucial for advancing our knowledge in this area.
Abstract
CommentReports on the presence of psilocybin and psilocin in Panaeolus foenesecii are confused, since both have been detected in some samples of this mushroom but not in all.It is usually considered a "latent psilocybin" mushroom, because psilocybin and psilocin may not necessarily be present in a particular specimen.